Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

2 Healthcare Stocks Showing Stability With A and B POWR Ratings

The healthcare industry should thrive with accelerated breakthrough developments and a growing market for telemedicine and personalized medicines. Moreover, given the lingering macroeconomic headwinds, fundamentally strong healthcare stocks, Amgen (AMGN), and Otsuka Holdings (OTSKY) showing Stability with A and B POWR Ratings could be ideal buys. Read more.

StockNews.com

Top 3 Stocks to Sell in April With Weak Fundamentals

The biopharmaceutical industry has been grappling with various challenges, including inflation, the Fed’s hawkish stance, and new regulatory concerns. Hence, it could be wise to avoid Syndax Pharmaceuticals (SNDX), Senseonics Holdings (SENS), and Sio Gene Therapies (SIOX) due to their bleak fundamentals. Keep reading….

StockNews.com

IBD 50 Stocks To Watch: This Drug Stock Up 36% In Six Weeks After Positive Trial News

Depression drug stock Intra-Cellular Therapies is up over 14% in April and 36% since mid-March.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Stay Away From These 3 Stocks With Bearish Momentum in April

Coupled with fears about an economic downturn, several other headwinds could keep the biotechnology industry under significant pressure. Given this backdrop, fundamentally weak biotech stocks Day One Biopharmaceuticals (DAWN), Northwest Biotherapeutics (NWBO), and Ocugen (OCGN), with bearish momentum, could be avoided in April. Read on….

StockNews.com

Novavax Plummets On Downgrade: Is It The Covid Engine That Couldn't?

Novavax has a solid platform but continues to face a $700 million litigation headwind, an analyst said Thursday as he downgraded NVAX stock.

Investors Business Daily

Supreme Court delays decision in abortion drug case

WASHINGTON — The Supreme Court gave itself more time on a decision expected Wednesday about a commonly used abortion drug, extending until Friday a temporary pause on a lower court ruling that would restrict availability of mifepristone.

Tribune News Service

Generic abortion pill maker sues FDA to protect access

A generic-mifepristone maker sued the U.S. Food and Drug Administration to protect access to the medical abortion pill amid a welter of litigation stretching from Texas to Washington.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Supreme Court temporarily extends access to abortion pill

The court has given itself until Friday to rule on whether to allow restrictions to take effect on mifepristone as legal challenges to its FDA approval continue.

Chicago Sun-Times

Generic abortion pill manufacturer sues FDA in effort to preserve access

GenBioPro, which makes a generic form of mifepristone, is suing the FDA seeking to preserve access to the drug amidst ongoing federal litigation.

WEKU

Legend Breaks Out After Leaked Documents Show Promise In $9.6 Billion Market

Legend Biotech is staring down a $9.6 billion opportunity, an analyst said Wednesday as LEGN stock soared on positive cancer test results.

Investors Business Daily

Trade unions to urge Labour to make manifesto commitment to devolving drug law

TRADE Unions have agreed to urge Labour to include a commitment to devolve drug powers to Scotland in their next General Election manifesto.

The National (Scotland)

Insulet Joins S&P 500 And Gets Ready To Pump Up New Breakout With 56% Growth

After Insulet jumped on news it was joining the S&P 500, PODD stock is wound up for a breakout with earnings due.

Investors Business Daily

The drug company that prospered without creating any drugs

The new drug looked so promising — except for that one warning sign.

Tribune News Service

Abortion foes urge Supreme Court to curb pill on eve of deadline

Abortion opponents urged the U.S. Supreme Court to allow new restrictions on a widely used pill to end pregnancy, presenting the justices with a stark choice on one of the country’s most divisive issues.

Tribune News Service

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Why Insiders Are Aggressively Buying This Under $1 Stock

While insiders are showing significant interest in penny stock Processa Pharmaceuticals (PCSA), the stock has witnessed a weak momentum over the past year. Let’s take a look at its key metrics to understand if there is any hope for sustainable share price appreciation. Read on.

Al Jazeera

Anti-abortion groups urge US top court to restrict abortion pill

Groups push the US Supreme Court to reject Biden administration request to halt a Texas ruling limiting access to pill.

The Independent UK

Abortion foes urge justices to allow limits on abortion drug

Lawyers for anti-abortion doctors are urging the Supreme Court to allow restrictions to take effect on a drug used in the most common method of abortion in the United States, while a lawsuit continues

Investors Business Daily

Why Top 1% Biotech Madrigal Pharmaceuticals Just Surged Closer To A Breakout

Madrigal snagged a breakthrough therapy designation for its liver disease treatment on Tuesday and MDGL stock surged closer to a buy point.

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Tesco to close eight in-store pharmacies this year as part of huge shake-up

Tesco announced in January that was to introduce a raft of changes to the business in order to “remain focused and competitive in a fast-changing market”

Investors Business Daily

Bellus Health Soars 99% As GSK Joins Buyout Bonanza With $2 Billion Deal

GSK added to a series of recent takeovers Tuesday with the $2 billion acquisition of Bellus Health. But BLU stock and GSK stock diverged.

The Street

Johnson & Johnson Tops Q1 Earnings Forecast On Consumer Unit Gains, Boosts Dividend

“Our first quarter results demonstrate strong performance across all three segments of our business," said CEO Joaquin Duato.

Investors Business Daily

Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom

Merck is acquiring Prometheus Bio in a well-timed $10.8 billion deal ahead of Keytruda's patent loss. The news sent RXDX stock flying Monday.

The Guardian - US

Conservatives love judicial activism – as long as the law is moved in their favor

Brazen judicial overreach to curb abortion access proves the right wing will abandon their principles to get their way

Axios

Supreme Court blocks lower court rulings restricting abortion pills

The court's decision comes less than a year after it overturned Roe v. Wade, arguing it did not have the power to create abortion policy.

The Guardian - US

Biden administration asks US supreme court to halt abortion pill restrictions

Limits slated to go into effect at 12.01am Saturday following lower court’s order revoking the FDA’s approval of mifepristone

1 … 38 39 40 41

People

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

the Justice Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.